https://www.cbsnews.com/news/melanoma-skin-cancer-vaccine-merck-moderna-progress/
0
0
12/13/22 at 10:18pm
Organization
CBS News
38 words
0
Comments
Moderna's stock soared after the COVID-19 vaccine maker detailed progress in developing a potential preventive shot for melanoma, a deadly form of skin cancer.
You are the first to view
Create an account
or login to join the discussion